- Corporate Update
- Core Behaviors
- History & Profile
- Executive Team
- Board of Directors
- Corporate Governance
- Corporate Videos
- CryoLife Outreach programs
- Quality and Safety
- Advanced Research
- News & Events
- Investor Relations
J. Patrick Mackin
Chairman, President, and Chief Executive Officer, CryoLife, Inc.
J. Patrick Mackin assumed the position of President and Chief Executive Officer of CryoLife in September 2014, he was appointed to the CryoLife Board in October 2014, and he was appointed Chairman of the Board in April 2015. Mr. Mackin has more than 20 years of experience in the medical device industry. Prior to joining CryoLife, Mr. Mackin served as President of Cardiac Rhythm Disease Management, the largest operating division of Medtronic, Inc., from August 2007 to August 2014. At Medtronic, he previously held the positions of Vice President, Vascular, Western Europe and Vice President and General Manager, Endovascular Business Unit. Prior to joining Medtronic in 2002, Mr. Mackin worked for six years at Genzyme, Inc. serving as Senior Vice President and General Manager for the Cardiovascular Surgery Business Unit and as Director of Sales, Surgical Products division. Before joining Genzyme, Mr. Mackin spent five years at Deknatel/Snowden-Pencer, Inc. in various sales and marketing roles and three years as an Officer in the U.S. Army. Mr. Mackin received an MBA from the Kellogg Graduate School of Management at Northwestern University and is a graduate of the U.S. Military Academy at West Point.
Thomas F. Ackerman
Executive Vice President and Chief Financial Officer, Charles River Laboratories
Thomas F. Ackerman has served as a Director of CryoLife since December 2003. Mr. Ackerman currently serves as a financial consultant to Charles River Laboratories International, Inc. Mr. Ackerman served as Executive Vice President and Chief Financial Officer of Charles River Laboratories International, Inc. until August 2015, (NYSE: CRL), a position he held since 2005. Charles River Laboratories is a full service, early-stage contract research organization. Mr. Ackerman joined Charles River Laboratories in 1988 with over eleven years of combined public accounting and international finance experience. He was named Controller, North America in 1992 and became Vice President and Chief Financial Officer in 1996. In 1999, he was named a Senior Vice President, and in 2005 he was named a Corporate Executive Vice President. Prior to joining Charles River Laboratories, Mr. Ackerman was an accountant at Arthur Andersen & Co. Mr. Ackerman is a Director of the University of Massachusetts Amherst Foundation. Mr. Ackerman received a B.S. in Accounting from the University of Massachusetts and became a certified public accountant in 1979 (his license is currently inactive).
James S. Benson
Retired Executive Vice President for Technical and Regulatory Affairs, AdvaMed (Advanced Medical Device Association)
James S. Benson has served as a Director on the CryoLife board since December 2005. During his career in the healthcare sector, Mr. Benson was employed by the US Food and Drug Administration from 1972 through 1992 where he held a number of senior positions. These include FDA Deputy Commissioner from 1988 until 1991, one year as FDA Acting Commissioner; Deputy Director of the FDA Center for Devices and Radiological Health from 1978 through 1988, and Director of that FDA center from 1991 until 1993. Mr. Benson went on to become the Executive Vice President for Technology and Regulatory Affairs at AdvaMed from 1993 until 2002. Upon his retirement, he became a director and presiding director of Cytomedix from 2004 through 2013, also serving on the Governing Board of Adventist Healthcare, Shady Grove Medical Center, from 2010 to the present. Mr. Benson holds a BS in Civil Engineering from the University of Maryland and an MS in Nuclear Engineering from the Georgia Institute of Technology.
Daniel J. Bevevino
Retired Vice President and Chief Financial Officer, Respironics, Inc.
Daniel J. Bevevino has served as a Director of CryoLife since December 2003. From 1996 until March of 2008, Mr. Bevevino served as the Vice President and Chief Financial Officer of Respironics, Inc. (Nasdaq: RESP), a company that develops, manufactures, and markets medical devices used primarily for the treatment of patients suffering from sleep and respiratory disorders, where he was employed since 1988. In March 2008, Respironics was acquired by Royal Philips Electronics (NYSE: PHG), whose businesses include a variety of medical solutions including medical diagnostic imaging and patient monitoring systems, as well as businesses focused on energy efficient lighting and consumer products. From March 2008 to December 31, 2009, Mr. Bevevino was employed by Philips as the Head of Post-Merger Integration – Respironics, as well as in various operating capacities, to help facilitate the integration of the combined companies. He is currently an independent consultant providing interim chief financial officer services and other business advisory services in the life sciences industry, and he currently serves as a director of one of the companies for which he provides services. He began his career as a certified public accountant with Ernst & Young (his license is currently inactive). Mr. Bevevino received a B.S. in Business Administration from Duquesne University and an MBA from the University of Notre Dame.
President and Chief Executive Officer
Jim joined Zyga Technology as President and Chief Executive Officer (CEO) in Nov. 2011. Prior, he served as President and CEO of Atritech, Inc. until it was sold to Boston Scientific and of Endocardial Solutions, Inc., which was acquired by St. Jude Medical. Jim began his career at American Hospital Supply, which was later acquired by Baxter Healthcare. During his 13 years at the company, Jim served in a variety of Sales & Marketing leadership positions. He holds a Bachelor of Science degree in Hospital Administration from the University of Arizona.
Ronald C. Elkins, M.D.
Professor Emeritus, Section of Thoracic and Cardiovascular Surgery, University of Oklahoma Health Science Center
Oklahoma City, Oklahoma
Ronald C. Elkins, M.D. has served as a Director of CryoLife since January 1994. Dr. Elkins is Professor Emeritus, Section of Thoracic and Cardiovascular Surgery, University of Oklahoma Health Sciences Center. Dr. Elkins has been a physician at the Health Science Center since 1971, and was Chief, Section of Thoracic and Cardiovascular Surgery, from 1975 to 2002. Dr. Elkins graduated from The University of Oklahoma College of Medicine and his Surgical and Cardiovascular Surgical training was at Johns Hopkins Hospital.
Ronald D. McCall, Esq.
Presiding Director, Attorney at Law
Ronald D. McCall, Esq. has served as a Director of CryoLife since January 1984. From 1985 to the present, Mr. McCall has been the owner of the law firm of Ronald D. McCall,
P. A., based m Tampa, Florida. Mr. McCall was admitted to the practice of law in Florida in 1961. Mr. McCall received his B.A. degree from the University of Florida in 1958 and LLB with honors 1961. Member of Phi Kappa Phi 1959. Florida Blue Key 1957; Hall of Fame 1957; Executive Editor University of Florida Law Review 1960. Chairman, Florida Council of Bar Association Presidents 1976-1977. Director of Hillsborough County Bar Association and President (1973-1974): Former member of Board of Directors, Winter Haven Citrus Growers Association; Board of Trustees and President Gulf Coast Lung Association 1978-1979.
Retired Managing Director, Bentley Associates L.P.
New York, New York
Harvey Morgan has served as a Director of CryoLife since May 2008. Mr. Morgan has more than 40 years of investment banking experience, with significant expertise in strategic advisory services, mergers and acquisitions, private placements, and underwritings. He served as a Managing Director of the investment banking firm Bentley Associates, L.P. from 2004 to December 31, 2012, and from 2001 to 2004 he was a Principal of Shattuck Hammond Partners, an independent investment banking and financial advisory firm. Mr. Morgan also serves on the Board of Family Dollar Stores, Inc. (NYSE: FDO) and previously served on the Board of Cybex International, Inc. (Nasdaq: CYBI). Mr. Morgan received his undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from The Harvard Business School.
Jon W. Salveson
Vice Chairman, Investment Banking, Piper Jaffray Companies
Jon W. Salveson has served as a Director of CryoLife since May 2012. Mr. Salveson is the Vice Chairman, Investment Banking and Chairman of the Healthcare Investment Banking Group at Piper Jaffray Companies (NYSE: PJC). He joined Piper Jaffray in 1993 as an associate, was elected Managing Director in 1999, and was named the Group Head of Piper Jaffray’s international healthcare investment banking group in 2001. Mr. Salveson was appointed Global Head of Investment Banking and a member of the Executive Committee of Piper Jaffray in 2004, and has served in his present position as Vice Chairman, Investment Banking since July 2010. Mr. Salveson also serves on the Board of Sunshine Heart, Inc. (NASDAQ: SSH). Mr. Salveson received his undergraduate degree from St. Olaf College and an M.M.M. in finance from the Kellogg Graduate School of Management at Northwestern University.